60574-4113 : Synagis 100 mg/ml Intramuscular Injection, Solution


NDC: 60574-4113
Labeler: Medimmune, LLC
Product Type: Human Prescription Drug
Drug Name:  Synagis
Dosage Form: Intramuscular Injection, Solution
Application #: BLA103770
Rev. Date: 


NDC Package Codes:

  • 60574-4113-1: 1 ML IN 1 VIAL, SINGLE‑DOSE (60574‑4113‑1)

Active Ingredients:

  • Palivizumab

Dosage Strength:

  • 100 mg/mL

Pharmaceutical Classes:

  • Antibodies
  • Monoclonal [CS]
  • Fusion Protein Inhibitors [MoA]
  • Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Related Products:

Based on records with the same trade name.
  • 60574-4114 Synagis 50 mg/.5ml Intramuscular Injection, Solution by Medimmune, LLC
  • 66658-230 Synagis 50 mg/.5ml Intramuscular Injection, Solution by Swedish Orphan Biovitrum Ab (Publ)
  • 66658-231 Synagis 100 mg/ml Intramuscular Injection, Solution by Swedish Orphan Biovitrum Ab (Publ)

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 60574-4113 QR Code

< Prev: 60568-123Next: 60574-4114 >

Related Discussions:

synagis
side effects long term...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.